Short Interest in Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF) Grows By 36.1%

Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF) was the target of a significant increase in short interest in the month of February. As of February 15th, there was short interest totalling 495,100 shares, an increase of 36.1% from the January 31st total of 363,800 shares. Based on an average daily trading volume, of 200 shares, the short-interest ratio is currently 2,475.5 days.

Kyowa Kirin Stock Performance

KYKOF opened at $12.32 on Thursday. Kyowa Kirin has a 52 week low of $12.32 and a 52 week high of $22.21. The business has a fifty day simple moving average of $14.43 and a 200-day simple moving average of $17.08.

Kyowa Kirin Company Profile

Kyowa Kirin Co, Ltd. engages in the research, development, manufacturing, marketing, and import/export of pharmaceuticals for oncology, nephrology, central nervous system, and immunology therapeutic areas in Japan, the United States, rest of the Americas, Europe, Asia, and internationally. Its products include ALLELOCK, an antihistamine agent for patients with various types of allergies; CONIEL, a calcium channel blocker for hypertension and angina pectoris; Crysvita, a recombinant human monoclonal IgG1 antibody against the phosphaturic hormone fibroblast growth factor 23; ESPO, a glycoprotein and human erythropoietin; NESP, an erythropoiesis stimulating agent; and GRAN, a human colony-stimulating factor.